Scrip Regulatory Affairs
Obtaining scientific advice from drug regulators - the good, the bad and the ugly
16 January 2013
Scrip Regulatory Affairs News
- The EMA at 20: CAT chair on where all the advanced therapies are, and Holoclar, the bright light of stem cell therapy
- The EMA at 20: CHMP chair on HTA, patient involvement and dealing with uncertainty
- Crisis at the EMA - but might Rasi return?
- Dutch take the lead on biosimilar switching - will others follow?
Other Informa News
Other Informa Analysis
Other Informa Editorials
Regulatory Affairs Pharma Features
Other Informa Features
Regulatory Affairs Pharma Comment
Other Informa Comments